PYXS

Pyxis Oncology, Inc. PYXS

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,769 of 2,925

Why it scores 18Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Top Institutional Holders

as of Q2 2026
$101.11M total
GordonMD Global Investments LP
$30.17M+143.2%
PFIZER INC
$19.48M0.0%
Laurion Capital Management LP
$14.75M-1.9%
VANGUARD CAPITAL MANAGEMENT LLC
$6.25M+2.1%
HealthInvest Partners AB
$2.91M+390.5%
BlackRock, Inc.
$2.61M+10.0%
Palo Alto Investors LP
$2.60M-14.5%
MARSHALL WACE, LLP
$2.50M+134.3%
RENAISSANCE TECHNOLOGIES LLC
$2.32M-13.1%
GEODE CAPITAL MANAGEMENT, LLC
$1.78M-1.0%
Woodline Partners LP
$1.58MNew
683 Capital Management, LLC
$1.38M-48.7%
JACOBS LEVY EQUITY MANAGEMENT, INC
$1.29M-7.0%
Longaeva Partners L.P.
$1.06M-29.7%
Decheng Capital LLC
$983.7K0.0%
VANGUARD FIDUCIARY TRUST CO
$912.0K+0.7%
JANE STREET GROUP, LLC
$873.2K-4.7%
STATE STREET CORP
$749.0K0.0%
MILLENNIUM MANAGEMENT LLC
$701.3K-41.4%
UBS Group AG
$467.2K-38.9%
Bank of New York Mellon Corp
$403.3K0.0%
ACADIAN ASSET MANAGEMENT LLC
$380.0K-12.1%
NORTHERN TRUST CORP
$373.1K+21.6%
NewEdge Wealth, LLC
$349.2K0.0%
XTX Topco Ltd
$333.9K-44.6%
See all 76 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PYXS

Earnings Per Share

13fpro.ai/company/PYXS

Loading ratio trend…

PYXS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Pyxis Oncology, Inc. (PYXS): stock profile, AI score and financials

Pyxis Oncology, Inc. (PYXS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PYXS at 18.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,769 of 2,925 stocks — the bottom half of the AI-ranked universe. Top institutional holders of PYXS by reported 13-F value include GordonMD Global Investments, PFIZER, Laurion Capital Management, based on the most recent SEC filings. PYXS trades on the Nasdaq exchange and files with the SEC under CIK 1782223. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PYXS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pyxis Oncology, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1782223 →